Hypofractionated intensity-modulated radiation therapy for prostate cancer
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000022951
- Lead Sponsor
- Department of Radiation Oncology, Graduate School of Medical and Dental Sciences, Niigata University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 39
Not provided
1) Patients who received radiotherapy for prostate. 2) Patients who received surgery for prostate. 3) Patients with uncontrolled active infection. 4) Cancer patients with a duplication of activity. 5) Patients with serious complications (uncontrollable collagen disease, heart disease, pulmonary disease, liver disease). 6) Mental diseases which prevent from registration of this trial. 7) Patients who received chemotherapy for prostate cancer. 8) Patients with inflammatory bowel disease. 9) Patients with severe or uncontrollable diabetes mellitus. 10) Risk organs are too close to the PTV to keep dose constraints. 11) Patients judged inappropriate for this study by the physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method